|
Join us on Thursday, 26 November 2026, at 16:00 East Africa Time for our LabCoP ECHO Session, where we discuss why domestic financing for diagnostics matters.
Why it matters
Diagnostics guide up to 70% of clinical decisions, yet receive less than 1% of health funding in LMICs. Persistent gaps in access to quality diagnostic tests undermine progress toward improved health outcomes and resilience to disease outbreaks. This session, organised in collaboration with Molbio Diagnostics, will explore practical strategies that countries are implementing to strengthen domestic financing, reduce donor dependency, and build sustainable diagnostic systems.
Country strategies we will explore:
- Integrated National Laboratory Strategic Plans: Develop a costed plan and unified budget, making a clearer investment case to finance ministries.
- Reagent rental and lease-to-own: shift from upfront equipment purchases to pay-per-test arrangements, with guaranteed reagent volumes.
- Public-private partnerships: leverage private sector couriers for hub-and-spoke sample referral networks, combined with decentralisation of mWRDs.
- National Health Insurance inclusion: coverage of essential tests, including those listed on the WHO Essential Diagnostics List.
Presenters
-
Mr Daniel Melese, Director, National Laboratory Capacity Building, EPHI/MOH, Ethiopia
-
Dr Clement Adesigbin, Acting National Coordinator, NTBLCP, Nigeria
🔗 Register for the session at:
https://us02web.zoom.us/webinar/register/WN__UJkbwKXRneSx9fMZva9yg
Meeting ID: 839 8919 5094
Passcode: 724287
Find your local time: https://aslm-org.zoom.us/u/kdo8NPu1x2
|